VistaGen Therapeutics, Inc.
VTGN
$3.16
$0.10443.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.10M | -13.64M | -14.09M | -12.96M | -10.73M |
| Total Depreciation and Amortization | 169.00K | 166.00K | 161.00K | 157.00K | 151.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 794.00K | 835.00K | 978.00K | 972.00K | 1.14M |
| Change in Net Operating Assets | -4.71M | 2.57M | 2.67M | 946.00K | -1.43M |
| Cash from Operations | -18.85M | -10.06M | -10.28M | -10.89M | -10.87M |
| Capital Expenditure | -65.00K | -88.00K | 0.00 | -61.00K | -42.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -723.00K | 615.00K | -422.00K | -7.73M | -5.43M |
| Cash from Investing | -788.00K | 527.00K | -422.00K | -7.79M | -5.47M |
| Total Debt Issued | 1.02M | -- | -- | -- | -- |
| Total Debt Repaid | -90.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 558.00K | 1.95M | 1.17M | 0.00 | 88.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.49M | 1.95M | 1.17M | 0.00 | 88.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.15M | -7.58M | -9.53M | -18.67M | -16.25M |